期刊文献+

粪便中检测K-ras基因突变对老年大肠癌诊断价值的研究 被引量:2

STUDY ON DIAGNOSTIC VALUE OF DETECTING K-ras GENE MUTATION IN STOOL FOR LARGE INTESTINAL CANCER IN THE ELDERLY
下载PDF
导出
摘要 探讨粪便K ras基因检测在老年大肠癌临床诊断中的价值。收集连续就诊的 2 3例老年大肠癌患者、2 0例结肠腺瘤性息肉患者及 2 0名健康老年查体者的粪便 ,并从中提取DNA ,应用等位基因特异性杂交技术检测粪便K ras基因第 12位密码子第 1、2位碱基突变情况。结果K ras基因突变率在大肠癌患者为 5 6 5 2 % (13/ 2 3) ,明显高于正常查体者的 5 % (1/ 2 0 ) (P <0 0 1) ,与结肠腺瘤性息肉组的 30 % (6 / 2 0 )比较 ,差异无显著性意义 (P >0 0 5 )。 92 31% (12 / 13)的大肠癌K ras基因突变位点发生在第 12位密码子第 2位碱基。研究表明 ,结肠癌患者组织及粪便中K ras基因突变的检出具有良好的一致性 ,提示粪便中检测K To study the significance of detection of K ras mutation in stool samples in the diagnosis of large intestinal cancer, stool and local tissue samples were collected from consecutively diagnosed patients, among them 23 cases suffered from large intestinal cancer, 20 cases from colorectal adenomatoid polyps and 20 healthy subjects. DNA was extracted from both the stool and the tissue, K ras gene mutations at the first and second base of codon 12 were studied by allele specific mismatch method in both of them. The results showed that K ras mutation rate in large intestinal cancer was 56 52%(13/23), which was much higher than 5%(1/20)in healthy subjects( P <0 01). The rate of large intestinal cancer group was not different significantly from that of the colorectal ademomatoid polyp group(30%,6/20)( P >0 05). There was a 92 31%(12/13)incidence of K ras mutation at the second base of codon 12 in large intestinal cancer. The results of detecting the K ras mutation were highly identical in both the stool and the tissue ( P <0 01). Our results indicate that detecting K ras mutations in stool samples provides a non invasive method in diagnosing large intestinal cancer of the elderly .
机构地区 解放军总医院
出处 《解放军医学杂志》 CAS CSCD 北大核心 2002年第11期1018-1020,共3页 Medical Journal of Chinese People's Liberation Army
关键词 大肠癌 诊断 K-RAS基因 粪便检验 癌基因 老年人 基因突变 K ras feces oncogenes colorectal neoplasms aged
  • 相关文献

参考文献2

二级参考文献3

共引文献20

同被引文献54

  • 1郑向东,雷平光.胃癌、大肠癌组织中p27蛋白的表达及其意义[J].实用临床医药杂志,2004,8(6):8-9. 被引量:2
  • 2欧玉荣,张洪福.大肠癌患者粪便p53基因检测及其临床意义[J].蚌埠医学院学报,2005,30(3):195-197. 被引量:2
  • 3Vasen HF, Stomwrken A, Menko FH, et al. MSH2 mutation carriers are at higher risk of cancer than MLHI mutation carvers: a study of hereditary nonpolyposis colorectal cancer families[J].J Clin Oncol,2001;19 (20):4074
  • 4Boun D.Three new colorectal cancer mutations found [J]. Lancet, 1999 ;353(9171 ) :2216
  • 5Srivastava S, Vemra M, Henson DE. Biomarkers for early detection of colon cancer [J].Clin Cancer Res,2001;7(5): 1118
  • 6Sikora K, Chan S,Evan G,et al.1C-myc oncogene expression in colorectal cancer[J]. Cancer,1987;59(7);1289
  • 7Sill H,Goldman JM Cross NC, et al.Homozygous deletions of p16 tumour suppressor gene are associated with lymphoid transformation ofchrorfic myeloid leukemia[J]. Blood, 1995; 85(8):2013
  • 8YamaoT, Matsumura Y, Shimada Y, et al. Abnormalexpression CD44v ariants in the exfoliatedcells in feces of patients with colorectal cancer. [J].Gastroenterology,1998; 144(6): 1196
  • 9Tanable KK, Ellis LM, SayaH.Expression of CD44R1, adhesion molecule in colorectal carcinoma and metastases [J]. Cancer, 1993; 341(8847):725.
  • 10Kim H, yang XL,Rosada C,et al. CD44 expression in colorectal adenomas is an early event occurring prior to K- ras and p53 gene mutation[J]. Arch Biochem Biophy,1994; 310(2):504

引证文献2

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部